Exousia Bio (LMMY) Equity Average (2022 - 2025)
Lamy (LMMY) has disclosed Equity Average for 4 consecutive years, with $10.9 million as the latest value for Q4 2025.
- Quarterly Equity Average rose 64175.68% to $10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Nov 2025, up 64175.68% year-over-year, with the annual reading at -$41991.5 for FY2024, N/A changed from the prior year.
- Equity Average hit $10.9 million in Q4 2025 for Lamy, up from -$16975.5 in the prior quarter.
- In the past five years, Equity Average ranged from a high of $10.9 million in Q4 2025 to a low of -$56850.0 in Q3 2024.
- Historically, Equity Average has averaged $1.1 million across 4 years, with a median of -$31627.0 in 2023.
- Biggest five-year swings in Equity Average: tumbled 144.37% in 2023 and later skyrocketed 64175.68% in 2025.
- Year by year, Equity Average stood at -$17611.0 in 2022, then crashed by 144.37% to -$43035.5 in 2023, then surged by 60.55% to -$16975.5 in 2024, then surged by 64175.68% to $10.9 million in 2025.
- Business Quant data shows Equity Average for LMMY at $10.9 million in Q4 2025, -$16975.5 in Q4 2024, and -$56850.0 in Q3 2024.